![](/img/cover-not-exists.png)
A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service
Westerhout, Kirsten, Treur, Maarten, Mehnert, Angelika, Pascoe, Katie, Ladha, Imran, Belsey, JonathanLanguage:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696998.2015.1044457
Date:
July, 2015
File:
PDF, 629 KB
english, 2015